Apotex to pay $24.1 million for fixing pravastatin prices
The Department of Justice has settled claims accusing Apotex of fixing the price of the generic drug pravastatin. The Florida-based company will pay a $24.1 million criminal fine....
Subscription required to view this article.
This content can only be accessed by FTCWatch subscribers. If you are an FTCWatch subscriber, please login
to access this content
If you do not currently subscribe to FTCWatch please contact us for subscription information:
FTCWatch is delivered in the following formats: via email alert and online at mlexwatch.com/ftcwatch